TY - JOUR
T1 - Quercetin inhibition of tumor invasion via suppressing PKCδ/ERK/ AP-1-dependent matrix metalloproteinase-9 activation in breast carcinoma cells
AU - Lin, Cheng Wei
AU - Hou, Wen Chi
AU - Shen, Shing Chuan
AU - Juan, Shu Hui
AU - Ko, Ching Huai
AU - Wang, Ling Mei
AU - Chen, Yen Chou
N1 - Funding Information:
This study was supported by the National Science Council of Taiwan (NSC95-2320-B-038-029-MY2 and NSC96-2320-B-038-031-MY3).
PY - 2008
Y1 - 2008
N2 - Quercetin (QUE; 3,5,7,3′,4′-tetrahydroxyflavone) has been shown to possess several beneficial biological activities including antitumor, anti-inflammation and antioxidant properties; however, the effects of QUE in preventing invasion by breast carcinoma cells are still undefined. Increases in the protein, messenger RNA and enzyme activity levels of matrix metalloproteinase (MMP)-9 were observed in 12-O-tetradecanoylphorbol-13-acetate (TPA)-treated MCF-7 cells, and these were blocked by QUE, but not by quercitrin or rutin. A translocation of protein kinase C (PKC)δ from the cytosol to the membrane followed by activation of extracellular signal-regulated kinase (ERK) and c-Jun/activator protein-1 (AP-1) by TPA was demonstrated, and TPA-induced MMP-9 activation and migration were inhibited by the pan PKC inhibitor, GF109203X, the specific PKCδ inhibitor, rottlerin, an ERK inhibitor (PD98059) and an AP-1 inhibitor (curcumin). Application of QUE significantly suppressed TPA-induced activation of the PKCδ/ ERK/AP-1-signaling cascade. To elucidate the importance of hydroxyl (OH) substitutions to QUE's inhibition of tumor migration, several structurally related flavones of QUE including 3′,4′-diOH, 3′,4′-diOCH3, 3,5,7-triOH, 3,4′,4′-triOH, 3,3′,4′-triOCH3, luteolin and fisetin were used. Results suggested that OH groups at both C3′ and C4′ play central roles in QUE's inhibition of TPA-induced MMP-9 activation and migration, and an additional OH at C3, C5 or C7 may increase the inhibitory potency of the 3′,4′-diOH flavone against TPA-induced MMP-9 activity and migration. The antitumor invasion and migration effects of breast carcinoma cells induced by QUE with the structure-activity relationship analysis were identified.
AB - Quercetin (QUE; 3,5,7,3′,4′-tetrahydroxyflavone) has been shown to possess several beneficial biological activities including antitumor, anti-inflammation and antioxidant properties; however, the effects of QUE in preventing invasion by breast carcinoma cells are still undefined. Increases in the protein, messenger RNA and enzyme activity levels of matrix metalloproteinase (MMP)-9 were observed in 12-O-tetradecanoylphorbol-13-acetate (TPA)-treated MCF-7 cells, and these were blocked by QUE, but not by quercitrin or rutin. A translocation of protein kinase C (PKC)δ from the cytosol to the membrane followed by activation of extracellular signal-regulated kinase (ERK) and c-Jun/activator protein-1 (AP-1) by TPA was demonstrated, and TPA-induced MMP-9 activation and migration were inhibited by the pan PKC inhibitor, GF109203X, the specific PKCδ inhibitor, rottlerin, an ERK inhibitor (PD98059) and an AP-1 inhibitor (curcumin). Application of QUE significantly suppressed TPA-induced activation of the PKCδ/ ERK/AP-1-signaling cascade. To elucidate the importance of hydroxyl (OH) substitutions to QUE's inhibition of tumor migration, several structurally related flavones of QUE including 3′,4′-diOH, 3′,4′-diOCH3, 3,5,7-triOH, 3,4′,4′-triOH, 3,3′,4′-triOCH3, luteolin and fisetin were used. Results suggested that OH groups at both C3′ and C4′ play central roles in QUE's inhibition of TPA-induced MMP-9 activation and migration, and an additional OH at C3, C5 or C7 may increase the inhibitory potency of the 3′,4′-diOH flavone against TPA-induced MMP-9 activity and migration. The antitumor invasion and migration effects of breast carcinoma cells induced by QUE with the structure-activity relationship analysis were identified.
UR - http://www.scopus.com/inward/record.url?scp=51849133195&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=51849133195&partnerID=8YFLogxK
U2 - 10.1093/carcin/bgn162
DO - 10.1093/carcin/bgn162
M3 - Article
C2 - 18628248
AN - SCOPUS:51849133195
SN - 0143-3334
VL - 29
SP - 1807
EP - 1815
JO - Carcinogenesis
JF - Carcinogenesis
IS - 9
ER -